125 related articles for article (PubMed ID: 38561905)
1. Canine glioma in the first year of life: 5 cases.
Dos Santos EC; Summers BA; Elbert JA; Miller DM; Rissi DR
J Vet Diagn Invest; 2024 Apr; ():10406387241242733. PubMed ID: 38561905
[TBL] [Abstract][Full Text] [Related]
2. Primary and secondary leptomeningeal gliomatosis in dogs.
Rissi DR; Reyes VAA; Donovan TA; Church ME; Howerth EW; Klang A; Woolard KD; Miller AD
Vet Pathol; 2024 Mar; 61(2):171-178. PubMed ID: 37577961
[TBL] [Abstract][Full Text] [Related]
3. Glioma with cribriform plate involvement in 6 dogs.
Reyes VAA; Howerth EW; Blas-Machado U; Platt SR; Pavarini SP; Castro LT; Church ME; Rissi DR
J Vet Diagn Invest; 2023 Nov; 35(6):800-805. PubMed ID: 37608783
[TBL] [Abstract][Full Text] [Related]
4. Canine spinal cord glioma.
Rissi DR; Barber R; Burnum A; Miller AD
J Vet Diagn Invest; 2017 Jan; 29(1):126-132. PubMed ID: 28074710
[TBL] [Abstract][Full Text] [Related]
5. Canine Gliomatosis Cerebri: Morphologic and Immunohistochemical Characterization Is Supportive of Glial Histogenesis.
Rissi DR; Donovan TA; Porter BF; Frank C; Miller AD
Vet Pathol; 2021 Mar; 58(2):293-304. PubMed ID: 33357125
[TBL] [Abstract][Full Text] [Related]
6. Doublecortin immunolabeling and lack of neuronal nuclear protein immunolabeling in feline gliomas.
Elbert JA; Rissi DR
J Vet Diagn Invest; 2022 Jul; 34(4):757-760. PubMed ID: 35678136
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous canine gliomas: overexpression of EGFR, PDGFRalpha and IGFBP2 demonstrated by tissue microarray immunophenotyping.
Higgins RJ; Dickinson PJ; LeCouteur RA; Bollen AW; Wang H; Wang H; Corely LJ; Moore LM; Zang W; Fuller GN
J Neurooncol; 2010 May; 98(1):49-55. PubMed ID: 19967449
[TBL] [Abstract][Full Text] [Related]
8. Safety and interim survival data after intracranial administration of M032, a genetically engineered oncolytic HSV-1 expressing IL-12, in pet dogs with sporadic gliomas.
Omar NB; Bentley RT; Crossman DK; Foote JB; Koehler JW; Markert JM; Platt SR; Rissi DR; Shores A; Sorjonen D; Yanke AB; Gillespie GY; Chambers MR
Neurosurg Focus; 2021 Feb; 50(2):E5. PubMed ID: 33524948
[TBL] [Abstract][Full Text] [Related]
9. Expression of FOXP3 in Canine Gliomas: Immunohistochemical Study of Tumor-Infiltrating Regulatory Lymphocytes.
Pi Castro D; José-López R; Fernández Flores F; Rabanal Prados RM; Mandara MT; Arús C; Pumarola Batlle M
J Neuropathol Exp Neurol; 2020 Feb; 79(2):184-193. PubMed ID: 31846038
[TBL] [Abstract][Full Text] [Related]
10. Microtubule-Associated Protein 2 Expression in Canine Glioma.
Demeter EA; Frank C; Rissi DR; Porter BF; Miller AD
Front Vet Sci; 2019; 6():395. PubMed ID: 31803765
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal Aberrations in Canine Gliomas Define Candidate Genes and Common Pathways in Dogs and Humans.
Dickinson PJ; York D; Higgins RJ; LeCouteur RA; Joshi N; Bannasch D
J Neuropathol Exp Neurol; 2016 Jul; 75(7):700-10. PubMed ID: 27251041
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical study of neural stem cell lineage markers in canine brains, gliomas, and a glioma cell line.
Yoshida K; Chambers JK; Uchida K
Vet Pathol; 2023 Jan; 60(1):35-46. PubMed ID: 36384382
[TBL] [Abstract][Full Text] [Related]
13. Doublecortin immunolabeling in canine gliomas with distinct degrees of tumor infiltration.
Reyes VAA; Donovan TA; Miller AD; Porter BF; Frank CB; Rissi DR
J Vet Diagn Invest; 2023 Mar; 35(2):187-192. PubMed ID: 36522858
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical evaluation of tissue factor, fibrin/fibrinogen and D-dimers in canine gliomas.
de la Fuente C; Pumarola M; Blasco E; Fernández F; Viu J; Añor S
Vet J; 2014 Jun; 200(3):387-92. PubMed ID: 24745770
[TBL] [Abstract][Full Text] [Related]
15. Isocitrate Dehydrogenase 1 Expression in Canine Gliomas.
Fraser AR; Bacci B; le Chevoir MA; Long SN
J Comp Pathol; 2018 Nov; 165():33-39. PubMed ID: 30502793
[TBL] [Abstract][Full Text] [Related]
16. COX-2 and c-kit expression in canine gliomas.
Jankovsky JM; Newkirk KM; Ilha MR; Newman SJ
Vet Comp Oncol; 2013 Mar; 11(1):63-9. PubMed ID: 22235799
[TBL] [Abstract][Full Text] [Related]
17. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
18. Molecular signalling pathways in canine gliomas.
Boudreau CE; York D; Higgins RJ; LeCouteur RA; Dickinson PJ
Vet Comp Oncol; 2017 Mar; 15(1):133-150. PubMed ID: 25808605
[TBL] [Abstract][Full Text] [Related]
19. Prognostic histopathologic features of canine glial tumors.
Merickel JL; Pluhar GE; Rendahl A; O'Sullivan MG
Vet Pathol; 2021 Sep; 58(5):945-951. PubMed ID: 34219560
[TBL] [Abstract][Full Text] [Related]
20. Presence of neural progenitors in spontaneous canine gliomas: A histopathological and immunohistochemical study of 20 cases.
Fernández F; Deviers A; Dally C; Mogicato G; Delverdier M; Cauzinille L; Gnirs K; Añor S; de la Fuente C; Fondevila D; Pumarola M
Vet J; 2016 Mar; 209():125-32. PubMed ID: 26831167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]